Suppliers / Suven Pharmaceuticals

Suven Pharmaceuticals

India 261 employees 2 duplicate records merged Updated 9 July 2026

Suven Pharmaceuticals is an API manufacturer based in India. It holds 20 active US drug master files across a filed portfolio of 9 molecules. Its GMP standing is certified by EMA. Customs aggregates show $42.0M of exports covering 153 molecules to 27 destinations in 2025.

20
active US DMFs
0
valid CEPs
1
registered plants
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Sangareddy, India Not on file

What they file, and where

Molecule Regulators Docs
Entacapone US FDA 4
Danofloxacin US FDA 2
Doxofylline US FDA 2
Fenoprofen US FDA 2
Gabapentin US FDA 2
Glycopyrronium US FDA 2
Iron Sucrose US FDA 2
Isosulfan Blue US FDA 2
Metyrosine US FDA 2

Also appears on these molecule pages

Entacapone API Glycopyrronium API Isosulfan Blue API Gabapentin API

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) 1 None
EMA None 1

Scale

Year Revenue Exports Destinations
2025 Not reported $42.0M 27
2024 Not reported $95.3M 24
2023 Not reported $112.0M 26
2022 Not reported $162.9M 26

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Suven Pharmaceuticals

Does Suven Pharmaceuticals hold a US DMF or a CEP?
Suven Pharmaceuticals holds 20 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Suven Pharmaceuticals manufacture?
1 registered site is on record, in India (Sangareddy). Every site is listed on this page with the register it came from.
What does Suven Pharmaceuticals make?
9 molecules are on record against Suven Pharmaceuticals, including Entacapone, Danofloxacin, Doxofylline and Fenoprofen. Each links through to that molecule's full manufacturer list.
Which regulators recognise Suven Pharmaceuticals's GMP?
Current GMP certificates are on record from EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Suven Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Apitoria Pharma shares 2 molecules Cohance Lifesciences shares 2 molecules MSN Laboratories shares 1 molecule Hetero shares 1 molecule Cipla shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts